These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 28710381)
1. Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors. Perge P; Butz H; Pezzani R; Bancos I; Nagy Z; Pálóczi K; Nyírő G; Decmann Á; Pap E; Luconi M; Mannelli M; Buzás EI; Tóth M; Boscaro M; Patócs A; Igaz P Sci Rep; 2017 Jul; 7(1):5474. PubMed ID: 28710381 [TBL] [Abstract][Full Text] [Related]
2. Analysis of circulating extracellular vesicle-associated microRNAs in cortisol-producing adrenocortical tumors. Perge P; Decmann Á; Pezzani R; Bancos I; Fassina A; Luconi M; Canu L; Tóth M; Boscaro M; Patócs A; Igaz P Endocrine; 2018 Feb; 59(2):280-287. PubMed ID: 29299796 [TBL] [Abstract][Full Text] [Related]
3. Analysis of circulating microRNAs in adrenocortical tumors. Szabó DR; Luconi M; Szabó PM; Tóth M; Szücs N; Horányi J; Nagy Z; Mannelli M; Patócs A; Rácz K; Igaz P Lab Invest; 2014 Mar; 94(3):331-9. PubMed ID: 24336071 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA Expression Profiling in Adrenal Myelolipoma. Decmann A; Perge P; Nyíro G; Darvasi O; Likó I; Borka K; Micsik T; Tóth Z; Bancos I; Pezzani R; Iacobone M; Patócs A; Igaz P J Clin Endocrinol Metab; 2018 Sep; 103(9):3522-3530. PubMed ID: 29982598 [TBL] [Abstract][Full Text] [Related]
5. Comparison of plasma and urinary microRNA-483-5p for the diagnosis of adrenocortical malignancy. Decmann A; Bancos I; Khanna A; Thomas MA; Turai P; Perge P; Pintér JZ; Tóth M; Patócs A; Igaz P J Biotechnol; 2019 May; 297():49-53. PubMed ID: 30940435 [TBL] [Abstract][Full Text] [Related]
6. Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy. Koperski Ł; Kotlarek M; Świerniak M; Kolanowska M; Kubiak A; Górnicka B; Jażdżewski K; Wójcicka A Oncotarget; 2017 Jul; 8(30):49191-49200. PubMed ID: 28423361 [TBL] [Abstract][Full Text] [Related]
7. Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients. Chabre O; Libé R; Assie G; Barreau O; Bertherat J; Bertagna X; Feige JJ; Cherradi N Endocr Relat Cancer; 2013 Aug; 20(4):579-94. PubMed ID: 23756429 [TBL] [Abstract][Full Text] [Related]
8. MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors. Patel D; Boufraqech M; Jain M; Zhang L; He M; Gesuwan K; Gulati N; Nilubol N; Fojo T; Kebebew E Surgery; 2013 Dec; 154(6):1224-8; discussion 1229. PubMed ID: 24238045 [TBL] [Abstract][Full Text] [Related]
9. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168 [TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs in adrenal tumors. Igaz P Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):155-159. PubMed ID: 30801265 [TBL] [Abstract][Full Text] [Related]
11. Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas. Creemers SG; van Koetsveld PM; van Kemenade FJ; Papathomas TG; Franssen GJ; Dogan F; Eekhoff EM; van der Valk P; de Herder WW; Janssen JA; Feelders RA; Hofland LJ Endocr Relat Cancer; 2016 Sep; 23(9):727-37. PubMed ID: 27535174 [TBL] [Abstract][Full Text] [Related]
12. Normalizers for microRNA quantification in plasma of patients with vulvar intraepithelial neoplasia lesions and vulvar carcinoma. Zalewski K; Misiek M; Kowalik A; Bakuła-Zalewska E; Kopczyński J; Zielińska A; Bidziński M; Radziszewski J; Góźdź S; Kowalewska M Tumour Biol; 2017 Nov; 39(11):1010428317717140. PubMed ID: 29299981 [TBL] [Abstract][Full Text] [Related]
13. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses. Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512 [TBL] [Abstract][Full Text] [Related]
14. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation. Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Patterson EE; Holloway AK; Weng J; Fojo T; Kebebew E Cancer; 2011 Apr; 117(8):1630-9. PubMed ID: 21472710 [TBL] [Abstract][Full Text] [Related]
17. microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection. Hamam R; Ali AM; Alsaleh KA; Kassem M; Alfayez M; Aldahmash A; Alajez NM Sci Rep; 2016 May; 6():25997. PubMed ID: 27180809 [TBL] [Abstract][Full Text] [Related]
18. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients. Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858 [TBL] [Abstract][Full Text] [Related]
19. [Pathogenic and diagnostic roles of microRNAs in adrenocortical tumours]. Nagy Z; Decmann Á; Perge P; Igaz P Orv Hetil; 2018 Feb; 159(7):245-251. PubMed ID: 29429354 [TBL] [Abstract][Full Text] [Related]
20. Discovery of extracellular vesicles derived miR-181a-5p in patient's serum as an indicator for bone-metastatic prostate cancer. Wang Y; Fang YX; Dong B; Du X; Wang J; Wang X; Gao WQ; Xue W Theranostics; 2021; 11(2):878-892. PubMed ID: 33391510 [No Abstract] [Full Text] [Related] [Next] [New Search]